Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Internet Searching May Get ‘Riskier’ For Patients After FDA Citations

This article was originally published in The Pink Sheet Daily

Executive Summary

“Sponsored searches” need to contain risk information, agency tells 14 firms in letters covering 48 products.

Related Content

Pfizer's "Online Resources" Are Over The Line For FDA
FDA Proposals For Studying Internet Promotions Raise Concerns
Socially Adept: Pharma Companies Must Proactively Gauge Risk Tolerance For Online Promotions, Experts Advise
FDA's Internet Promotion Policy: Christmas Cards In Lieu Of Guidance?
FDA's Bulk Advertising Citations Continue: CSL Behring And Talecris Get Letters For Their Alpha1 Proteinase Inhibitors
PhRMA Open To User Fees To Support Oversight Of Internet Drug Promotion
Google Creates New Formats To Include Risk Information In Sponsored Search Results
PhRMA's Web Search Solution: Add Icon Or Generic Risk Statement In Results
DTC Ad Spending Fell In 2008 And Pharma Should Respond By Rebalancing Budgets
New Media Is The New Frontier For Drug Promotion





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts